e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Phenotyping symptomatic asthma using proximal and peripheral exhaled nitric oxide
J. Puckett, A. Aledia, D. Shelley, H. W. Shin, S. Galant, S. George (Irvine, CA, Orange, CA, United States Of America)
Source:
Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Session:
Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Session type:
Thematic Poster Session
Number:
3926
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Puckett, A. Aledia, D. Shelley, H. W. Shin, S. Galant, S. George (Irvine, CA, Orange, CA, United States Of America). Phenotyping symptomatic asthma using proximal and peripheral exhaled nitric oxide. Eur Respir J 2008; 32: Suppl. 52, 3926
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Increased exhaled nitric oxide in nonatopic asthma
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003
Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
Diagnosing asthma using exhaled nitric oxide (eNO) measurements
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003
Fractionated exhaled nitric oxide in COPD patients
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007
Applications of exhaled and nasal nitric oxide in airway diseases
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
Measurement of exhaled nitric oxide in children
Source: Guideline 2002
Year: 2002
Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Exhaled nitric oxide in mustard airway disease
Source: International Congress 2018 – Occupational and environmental lung diseases: influence on the airway and interstitium
Year: 2018
Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Exhaled nitric oxide in the assessment of asthma control
Source: Eur Respir J 2007; 30: Suppl. 51, 18s
Year: 2007
Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003
Exhaled nitric oxide and cough variant asthma
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept